Intervention

Nateglinide

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions6

Lead sponsors shown3

Clinical trials

4 shown

Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin SecretionNCT01030952 · 2009-12-01

Study of the Durability of Glycemic Control With NateglinideNCT00858013 · 2009-04-24

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or RosiglitazoneNCT00402909 · 2006-11-01

Efficacy and Safety of Nateglinide Treatment in Renal Transplant RecipientsNCT00319189 · 2002-11-01

Common conditions

Diabetes Mellitus, Type 21 Posttransplant Diabetes Mellitus1 Posttransplant Impaired Glucose Tolerance1 Renal Transplant Recipients1 Type 2 Diabetes1 Type 2 Diabetes Mellitus1

Leading sponsors

Novartis Pharmaceuticals2 Ajou University School of Medicine1 University of Oslo School of Pharmacy1

Trial status mix

COMPLETED4

Phase mix

PHASE44

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.